➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Moodys
Dow
Mallinckrodt
McKinsey

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,408,893


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,408,893
Title:Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
Abstract: The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
Inventor(s): Niemoeller; Elisabeth (Frankfurt am Main, DE), Muehlen-Bartmer; Isabel (Frankfurt am Main, DE), Silvestre; Louise (Paris, FR), Boka; Gabor (Paris, FR), Miossec; Patrick (Paris, FR)
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main, DE)
Application Number:13/595,590
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 9,408,893

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,408,893

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
11179149Aug 29, 2011

International Family Members for US Patent 9,408,893

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 087693 ⤷  Free Forever Trial
Australia 2012300978 ⤷  Free Forever Trial
Brazil 112014004726 ⤷  Free Forever Trial
Canada 2846413 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Baxter
McKinsey
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.